1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United Kingdom Pharmaceuticals and Healthcare Report Q1 2016

United Kingdom Pharmaceuticals and Healthcare Report Q1 2016

  • January 2016
  • -
  • Business Monitor International
  • -
  • 107 pages

Includes 3 FREE quarterly updates

BMI View: Sustained pharmaceutical and healthcare market growth in the UK will create improvedopportunities for drugmakers over the next 10 years. Despite pressure on revenues due to cost containmentmeasures, the adoption of health innovations will continue to be a competing policy priority, as illustratedby the recent creation of a market access office under the National Institute for Health and Care Excellenceto facilitate the domestic diffusion of new health products, as well as the use of different financingmechanisms to ensure access to value-adding innovations. Meanwhile, the robust R&D base in the countrywill continue to attract investment in biotechnologies and next-generation treatments, including throughincreasing collaborations between pharmaceutical firms and universities as well as other stakeholders inthe life sciences.

Headline Expenditure Projections

- Pharmaceuticals: GBP25.07bn (USD41.11bn) in 2014 to GBP25.78bn (USD39.19bn) in 2015; 2.8% inlocal currency terms and -4.7% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: GBP150.95bn (USD247.56bn) in 2014 to GBP155.30bn (USD236.06bn) in 2015; 2.9% inlocal currency terms and -4.6% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

United Kingdom Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Kingdom 2013-2019) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Kingdom 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019) 23
Generic Drug Market Forecast 24
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (United Kingdom 2013-2019) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (United Kingdom 2013-2019) 32
Industry Risk Reward Indices 33
Western Europe Risk/Reward Index 33
United Kingdom Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 43
Pricing Regime 45
Reimbursement Regime 51
Market Overview 54
Healthcare Sector 55
Table: Healthcare Resources (United Kingdom 2009-2014) 60
Table: Healthcare Personnel (United Kingdom 2009-2014) 60
Table: Healthcare Activity (United Kingdom 2009-2014) 61
Research And Development 61
Clinical Trials 63
Epidemiology 64
Competitive Landscape 67
Pharmaceutical Industry 67
Table: Leading Pharmaceutical Corporations' UK market share, 2014 67
Table: Multinational Market Activity 72
Pharmaceutical Distribution 73
Pharmaceutical Retail Sector 73
Table: UK-Registered Retail Pharmacies, 2010 75
Company Profile 76
GlaxoSmithKline 76
AstraZeneca 82
Pfizer 87
Novartis 90
Sanofi 93
Demographic Forecast 96
Table: Population Headline Indicators (United Kingdom 1990-2025) 97
Table: Key Population Ratios (United Kingdom 1990-2025) 97
Table: Urban/Rural Population and Life Expectancy (United Kingdom 1990-2025) 98
Table: Population By Age Group (United Kingdom 1990-2025) 98
Table: Population By Age Group % (United Kingdom 1990-2025) 99
Glossary 101
Methodology 103
Pharmaceutical Expenditure Forecast Model 103
Healthcare Expenditure Forecast Model 103
Notes On Methodology 104
Risk/Reward Index Methodology 105
Index Overview 106
Table: Pharmaceutical Risk/Reward Index Indicators 106
Indicator Weightings 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.